The value of Intellectual property (Read: Patents) is increasing in today’s technological world. The market, value, growth of any company depends on the technological prowess it has or in other…
Research expenses are mandatory for all technology firms and they have to support research, even during these recession times, as any breakthrough can aid them in surmounting this recession demon.…
Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. filed Three Inter Partes Review (IPR) petetions on Monday December 15, 2014. Out of three, two IPRs were filed against BIOGEN…